Delivery Order SPE2DB20D1109-SPE2DB25FP78F
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,282.68 for Progesterone 100 mg capsules (100-count) on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,993.33 for Progesterone 200 mg capsules (100-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a contract value of $1,503.95. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $10,032.28 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,653.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $35,436.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.40 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,304.00 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This competitive, firm fixed-price delivery order was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP78FDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,381.85 for 100 capsules of Progesterone 200 mg on September 17, 2025, with completion anticipated by September 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a primary supplier for the Defense Health Agency and other government healthcare systems. The company's extensive portfolio under the DLA framework encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific progesterone delivery order represents a routine pharmaceutical procurement in support of military medical supply chain requirements and demonstrates the company's ongoing capability to fulfill federal healthcare needs through its established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/17/25 |